Veterans’ RightsAn independent resource for veterans
← All decisions
Remanded (sent back)

The Board has determined that the Veteran's claims for carotid artery disease are remanded due to potential exposure to herbicide agents during service.

The deciding factor: The Veteran is presumed exposed to herbicide agents and his carotid artery disease may be secondary to his service-connected coronary artery disease.

Claimed conditions
hypertension, fibromyalgia, erectile dysfunction, low testosterone, carotid artery disease
How they argued it
Secondary to another service-connected condition
Exposure basis
Burn pits / airborne hazards
Rating assigned
None in this decision
Decision date
September 14, 2020
Citation
20060330

This is a plain-language summary generated by AI from a public Board of Veterans’ Appeals decision. It can contain errors — always verify against the original. Look up the original decision on VA.gov (opens in a new tab) using citation 20060330.

What this means for you

A remand is not a loss. The Board sent the case back for more development — often a new exam or missing records — before making a final decision. Many remands later end in a grant, and the decision spells out exactly what the Board wanted to see.

What you can do next

Related decisions

Other Board decisions on a similar condition or argued the same way.

Free starter guide for your own claim

Reading this because you were denied or under-rated? Get the plain-English next steps — your appeal options, the deadline that protects you, and how appeals like yours turn out. One email, no spam.

We will only use this to send the guide. No spam, unsubscribe any time. We never sell your information.

We are not the VA. Veterans’ Rights is an independent resource built for veterans. We are not the U.S. Department of Veterans Affairs, not part of the government, and not endorsed by any government agency.

This is general information, not legal advice. For advice about your own situation, talk to a VA-accredited representative — many help for free.